Tech Company Financing Transactions
Novan Funding Round
Novan, operating out of Morrisville, secured $2.4 million from private investors.
Transaction Overview
Company Name
Announced On
12/30/2015
Transaction Type
Venture Equity
Amount
$2,430,569
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4105 Hopson Rd.
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Novan, Inc. (Nasdaq: NOVN) is a pharmaceutical company focused on redefining the standard of care in dermatology through the development and commercialization of innovative therapies using the Company's nitric oxide platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paula Stafford
Chief Technical Officer
Carri Geer
Vice President
Tomoko Maeda-Chubachi
VP - Bus. Development
Elizabeth Messersmith
VP - Finance
John Gay
Browse more venture capital transactions:
Prev: 12/30/2015: Procore Technologies venture capital transaction
Next: 12/31/2015: Kapteyn-Murnane Laboratories venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs